[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 16, Issue 2 (summer 2016) ::
J Ardabil Univ Med Sci 2016, 16(2): 169-177 Back to browse issues page
Effects of Metformin on Serum Levels of Secreted Klotho and Leptin in PCOS Women
Savadali Saifi Novashnag , SHahrbanou Oryan, Akram Eidi, Parichehr Yaghmaei
Department of Biology, Faculty of Basic Sciences, Science and Research branch, Islamic Azad University, Tehran, Iran
Abstract:   (8709 Views)

Background & objectives: PCOS is one of the most prevalent endocrinology disorders and 5-15% of women in fertility age suffer from this disease. The leptin a 167 amin oacid peptide is secreted from adipose tissue in a pulsatile fashion. This hormone is essential in regulation of normal body weight and like the klotho hormone that is expressed most prominently in the distal convoluted tubules of kidneys and the choroid plexus of brain, has a role in pathogenesis of reproductive disorders. The secreted klotho has been identified as an anti-aging and anticancer hormone. Metformin is an anti-hyperglycemic drug with anorexic properties that could influence the function of ovaries.

Methods: In this case-control study, 45 patients with PCOS who referred to the infertility center of Jahad-e-Daneshgahi in the city of Ardabil from March 2013 through March 2014, were selected in accordance with the NIH criteria. Moreover, 45 healthy women were also selected as the control group. BMIs were calculated by division of weight by square of height and insulin resistance index was calculated by HOMA-IR model. Leptin and klotho serum levels were measured using ELISA kit. In the case group the measurements were repeated after a one-month course of therapy with metformin. Data analysis performed by SPSS software using dependent and independent t-tests.

Results: PCOS patients showed significant improvements after receiving metformin for one month.
Patients’ weights showed some decline. Fasting plasma glucose levels and insulin resistance decreased significantly (p<0.01). Hormonal assays indicated significant decrease in leptin and insulin levels and rise in Klotho levels. BMIs did not change meaningfully. Measurements of leptin and klotho levels showed a decrease in mean leptin levels from 34.74 to 28.41 ng/l and the level of klotho increased from 4.01 to 5.43 ng/l.

Conclusion: This study showed that metformin treatment can cause a rise in klotho and a decrease in leptin levels without considerable effects on the weights of women with PCOS. Probably, leptin exerts its physiological effects in low concentrations while klotho in contrast acts physiologically in higher concentrations.

Keywords: Polycystic Ovary Syndrome, Leptin, Klotho, Metformin
Full-Text [PDF 141 kb]   (1714 Downloads)    
Type of Study: article | Subject: General
Received: 2015/12/15 | Accepted: 2016/02/23 | Published: 2016/06/29
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saifi Novashnag S, Oryan S, Eidi A, Yaghmaei P. Effects of Metformin on Serum Levels of Secreted Klotho and Leptin in PCOS Women. J Ardabil Univ Med Sci. 2016; 16 (2) :169-177
URL: http://jarums.arums.ac.ir/article-1-1099-en.html

Volume 16, Issue 2 (summer 2016) Back to browse issues page
مجله دانشگاه علوم پزشکی اردبیل Journal of Ardabil University of Medical Sciences
Persian site map - English site map - Created in 0.1 seconds with 32 queries by YEKTAWEB 4044